Clinical trials

  • 6-FLUORO-5-[4-[(5-FLUORO-2-METHYL-3-OXO-4H-QUINOXALIN-6-YL)METHYL]PIPERAZIN-1-YL]-N-METHYLPYRIDINE-2-CARBOXAMIDE for Advanced solid malignancies|Ovarian cancer|Breast cancer|Pancreatic cancer|Prostate cancer|IDH-mutant glioma|Non-small cell lung cancer|Endometrial cancer|HER2-positive metastatic solid tumours
  • nivolumab for Melanoma
  • Lamivudine; Doravirine; Tenofovir disoproxil for HIV infection
  • ADMILPARANT for Progressive pulmonary fibrosis
  • ASP2138 for Gastroesophageal junction adenocarcinoma | Gastric adenocarcinoma | Pancreatic adenocarcinoma
  • PEMBROLIZUMAB for Muscle-invasive bladder cancer
  • ADMILPARANT for Idiopathic pulmonary fibrosis
  • IBERDOMIDE for Multiple myeloma
  • SACITUZUMAB TIRUMOTECAN for Non-small cell lung cancer
  • ANIFROLUMAB for Cutaneous lupus erythematosus
  • PEMBROLIZUMAB for Squamous cell carcinoma of head and neck
  • MCA-derived mesenchymal stromal cells (MSC) for Kidney transplant rejection | Biopsy-proven acute rejection (BPAR)